FDA Drafts Guidance on Replacing Reagents for IVD Devices Post author:Sam Post published:February 15, 2018 Post category:The GMP Letter The FDA issued draft guidance to provide updates on in vitro diagnostics’ replacement reagents. Source: The GMP Letter You Might Also Like Senators Question Digital Health Pre-Cert Program November 8, 2018 EC Details How Legacy Devices Will Be Managed in Eudamed March 4, 2021 No Regulatory Changes for Australia’s Personalized and 3D Printed Devices June 7, 2018